Explore more publications!
Reunion Health News
Got News to Share?

Reunion Health News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Reunion Health News.

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

Press releases published on February 18, 2026

BrainsWay Reports Cigna’s Evernorth Behavioral Health to Eliminate Prior Authorization Requirements for TMS Coverage, Accelerating Access to Care
30 minutes ago

BrainsWay Reports Cigna’s Evernorth Behavioral Health to Eliminate Prior Authorization Requirements for TMS Coverage, Accelerating Access to Care

Indeterminate GlobeNewswire
Thérapeutique Knight annonce le dépôt d’une autorisation réglementaire pour NIKTIMVO® (l’axatilimab) au Brésil
30 minutes ago

Thérapeutique Knight annonce le dépôt d’une autorisation réglementaire pour NIKTIMVO® (l’axatilimab) au Brésil

Indeterminate GlobeNewswire
Knight Therapeutics Announces Regulatory Submission of NIKTIMVO® (Axatilimab) in Brazil
30 minutes ago

Knight Therapeutics Announces Regulatory Submission of NIKTIMVO® (Axatilimab) in Brazil

Indeterminate GlobeNewswire
Medline announces participation in the Barclays 28th Annual Global Healthcare Conference
30 minutes ago

Medline announces participation in the Barclays 28th Annual Global Healthcare Conference

Indeterminate GlobeNewswire
Medicenna Therapeutics Announces Participation in Upcoming Conferences
30 minutes ago

Medicenna Therapeutics Announces Participation in Upcoming Conferences

Indeterminate GlobeNewswire
Crescent Biopharma Announces First Patient Dosed in ASCEND Phase 1/2 Clinical Trial of CR-001 for the Treatment of Advanced Solid Tumors
30 minutes ago

Crescent Biopharma Announces First Patient Dosed in ASCEND Phase 1/2 Clinical Trial of CR-001 for the Treatment of Advanced Solid Tumors

Indeterminate GlobeNewswire
NervGen Pharma to Participate at Upcoming Investor Conferences
30 minutes ago

NervGen Pharma to Participate at Upcoming Investor Conferences

Indeterminate GlobeNewswire
Constant Therapy Health Joins American Heart Association Innovators’ Network to Advance AI‑Driven Neurorehabilitation
37 minutes ago

Constant Therapy Health Joins American Heart Association Innovators’ Network to Advance AI‑Driven Neurorehabilitation

Indeterminate GlobeNewswire
Appili Therapeutics Announces Closing of Second Tranche of Non-Brokered Private Placement
41 minutes ago

Appili Therapeutics Announces Closing of Second Tranche of Non-Brokered Private Placement

Indeterminate GlobeNewswire
Tilray Brands and the Carlsberg Group Enter into an Exclusive Multi-Year U.S. Brewing and Commercial Partnership
an hour ago

Tilray Brands and the Carlsberg Group Enter into an Exclusive Multi-Year U.S. Brewing and Commercial Partnership

Indeterminate GlobeNewswire
Ocugen to Host Conference Call on Wednesday, March 4, 2026 at 8:30 A.M. ET to Discuss Business Updates and Fourth Quarter and Full Year 2025 Financial Results
an hour ago

Ocugen to Host Conference Call on Wednesday, March 4, 2026 at 8:30 A.M. ET to Discuss Business Updates and Fourth Quarter and Full Year 2025 Financial Results

Indeterminate GlobeNewswire
Immunocore to report fourth quarter and full year 2025 financial results and host call on February 25, 2025
an hour ago

Immunocore to report fourth quarter and full year 2025 financial results and host call on February 25, 2025

Indeterminate GlobeNewswire
EyePoint Appoints Michael Campbell as Chief Commercial Officer
an hour ago

EyePoint Appoints Michael Campbell as Chief Commercial Officer

Indeterminate GlobeNewswire
Advanced Biomed Inc. Announces 1 for 20 Share Consolidation
an hour ago

Advanced Biomed Inc. Announces 1 for 20 Share Consolidation

Indeterminate GlobeNewswire
Tango Therapeutics to Report Fourth Quarter 2025 Financial Results and Participate in Three Upcoming Investor Conferences
an hour ago

Tango Therapeutics to Report Fourth Quarter 2025 Financial Results and Participate in Three Upcoming Investor Conferences

Indeterminate GlobeNewswire
Harrow To Report Fourth Quarter and Year-End 2025 Financial Results After Market Close on March 2, 2026
an hour ago

Harrow To Report Fourth Quarter and Year-End 2025 Financial Results After Market Close on March 2, 2026

Indeterminate GlobeNewswire
Aquestive Therapeutics Appoints Internationally Recognized Allergist Dr. Matthew Greenhawt as Chief Medical Officer
an hour ago

Aquestive Therapeutics Appoints Internationally Recognized Allergist Dr. Matthew Greenhawt as Chief Medical Officer

Indeterminate GlobeNewswire
Axsome Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
an hour ago

Axsome Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

Indeterminate GlobeNewswire
ADMA Biologics to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
an hour ago

ADMA Biologics to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

Indeterminate GlobeNewswire
Cullinan Therapeutics to Participate in Fireside Chat at the Citi 2026 Virtual Oncology Leadership Summit
an hour ago

Cullinan Therapeutics to Participate in Fireside Chat at the Citi 2026 Virtual Oncology Leadership Summit

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions